Market Research Report Store Sierra Oncology Inc (SRRA) - Pharmaceuticals & Hea

Market Research Report Store has been recently published a fresh report"Sierra Oncology Inc (SRRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile-Market Research Report Store＂.It is a professional and in-depth study. Complete Report Available at: @ https://www.marketresearchreportstore.com/ Request a sample, click here [email protected] Description Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a drug development company that develops and commercializes DNA Damage Response (DDR) therapeutics for the treatment of cancer. The company’s lead product candidate includes SRA737, an orally bioavailable small molecule inhibitor of Checkpoint kinase 1 (Chk1), a key cell cycle checkpoint and central regulator of the DDR network. It is also developing SRA141, a small molecule inhibitor of the cell division cycle 7 kinase (Cdc7). The company has presence in the US and Canada. Sierra Oncology is headquartered in Vancouver, British Columbia, Canada. Sierra Oncology Inc (SRRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.